CFO transition
Fathom Holdings Inc. CFO transition: Daniel Weinmann to succeed Marco Fregenal
Fathom Holdings Inc. reported in a Form 8-K filed June 17, 2026 that Daniel Weinmann will succeed Marco Fregenal as Chief Financial Officer, effective June 16, 2026.
In the filing's words
On June 16, 2026, the Board appointed Daniel Weinmann, age 41, to serve as Chief Financial Officer, effectively immediately. As Chief Financial Officer, Mr. Weinmann will assume the roles of principal financial officer and principal accounting officer of the Company.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Fathom Holdings Inc. (FTHM) |
|---|---|
| Event | Transition |
| Incoming | Daniel Weinmann |
| Outgoing | Marco Fregenal |
| Title in the filing | Chief Financial Officer |
| Effective | June 16, 2026 |
| 8-K filed | June 17, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Vice President of Finance, Fathom Holdings Inc. |
| SEC CIK | 0001753162 |
Fathom Holdings Inc. reported this change in a Form 8-K, Item 5.02, filed June 17, 2026. The filing's own words are quoted above.
Other records naming Marco Fregenal
1The outgoing officer on this record, matched by name. Career line.
2026-03-30 · 10-K signature
Marco Fregenal signed Fathom Holdings Inc.'s annual report as President and Chief Executive Officer, Director (Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer)
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Daniel Weinmann? Send a correction with the primary source.